The beauty of these rankings is their ability to pinpoint what’s moving and showing strength—giving us a chance to capitalize on the most profitable opportunities, right now.

But sometimes, the best setups take years to develop. Investors with a longer-term perspective often see their patience rewarded.

A prime example? Certain groups within healthcare, which have delivered impressive returns over time. The iShares U.S. Healthcare Providers ETF ($IHF) is a standout, with nearly +1,000% gains since the GFC lows.

However, in the past four years, it’s been flat.

While this space has been digesting those astronomical gains, the longer-term outlook looks stronger than ever.

Over the same period, while the broader market has surged by nearly +50%, $IHF has been dormant. But that could be about to change.

If $IHF breaks to new all-time highs, it would signal that this space is ready for the next leg higher—and investors could be positioned for substantial upside.

This could be the perfect moment to rediscover what’s been quietly brewing in healthcare.

Below is my weekly video for members of Macke's Retail Roundup.

If a few weeks ago we had 'The Week From Hell" as I called it, then this week was "The Best Week Ever". 

My Retail Roundup Portfolio ripping right now thanks to the changing market sentiment. And our newest position just had its second-best week as a public company. 

So I'm in a great mood! 

Below is my latest update on the portfolio, as well as a couple of new ideas for stocks that I could be interested in soon.

I talk all the time about how the options market makers are not stupid. Options are priced the way they are, when they are, because options market makers know what they are doing. Usually.

But once in a blue moon, they can get caught sleeping. 

I think I may have found one such opportunity and I want to pounce on it today.

In today’s Daily Digest, we’ll review the following:

1. No new positions today.
2. Rolling XRT to July options.
3. Closed IBB at profit target.
4. Current status of open campaigns.
5. Volatility Snapshot.

Let’s dig in!

From the desk of Steve Strazza @Sstrazza

Our Hall of Famers list is composed of the 150 largest US-based stocks.

These stocks range from the mega-cap growth behemoths like Apple and Microsoft – with market caps in excess of $2T – to some of the new-age large-cap disruptors such as Moderna, Square, and Snap.

It has all the big names and more.

It doesn’t include ADRs or any stock not domiciled in the US. But don’t worry; we developed a separate universe for that. Click here to check it out.

The Hall of Famers is simple.

We take our list of 150 names and then apply our technical filters so the strongest stocks with the most momentum rise to the top.

Let’s dive right in and check out what these big boys are up to.

Here’s this week’s list:

*Click table to enlarge view

We filter out any laggards that are down -5% or more relative to the S&P 500 over the trailing month.

Then, we...

Walmart $WMT just delivered mixed results, and the market punished the stock.

Shares slipped -0.5% on the day, marking the second consecutive negative earnings reaction for the world’s largest retailer.

It’s not that the numbers were terrible. They weren’t. 

But the guidance was a huge disappointment. 

With revenue growth flattening and consumer trends appearing somewhat fragile, investors are clearly adopting a more cautious stance.

Additionally, the stock is exhibiting signs of exhaustion. It has carved out a potential multi-month distribution pattern.

Walmart’s still a bellwether for the U.S. consumer. 

However, if this stock starts to break down, it might be indicating more about the market than just the company.

So what else did we learn from yesterday's earnings reactions? Let's dive into the details.

*Click the image to enlarge it

Steris $STE had the best reaction score after...

Here's the replay and chartbook from the May 16 Weekly Strategy Session.

Be sure to join us on Thursday mornings and maximize your return potential.

Every day, we sift through the filings to spot where the real conviction lies — cutting through the noise to highlight the most meaningful insider moves.

Here's what stood out today:

📌 Coupang $CPNG – Greenoaks Capital Partners bought $37.50 million in the ”Amazon of South Korea.”

It’s one of the biggest insider buys we’ve seen all year. Following the purchase, the firm now holds 55.2 million shares, representing about 3.66% of Coupang’s outstanding float among institutional holders.

Steve just wrote about CPNG this weekend. Check it out here.

📌 UnitedHealth Group $UNH – The CEO and CFO just stepped up with $30 million in combined stock purchases via Form 4s.

This comes at a make-or-break moment — shares have...

From the Desk of Steve Strazza @Sstrazza

We love our bottoms-up scans here at All Star Charts. We tend to get really creative when making new universes as we want to be sure they will deliver us the best opportunities the market has to offer.

However, when it comes to this one, it couldn't be any simpler!

With the goal of finding more bullish setups, we have decided to expand one of our favorite scans and broaden our regular coverage of the largest US stocks.

Welcome to The Junior Hall of Famers.

This scan is composed of the next 150 largest stocks by market cap, those that come after the top 150 and are thus covered by the Hall of Famers universe. Many of these names will someday graduate and join our original Hall Of Famers list. The idea here is to catch these big trends as early on as possible.

There is no need to overcomplicate things. Market cap is a quality filter at the end of the day. It only grows if price is rising. That's good enough for us.

The bottom line is it is a bull market. We...

Off the back of last week’s crypto rally, the Crypto Industry Innovators ETF ($ETF) closed at new highs.

As markets continue their recovery, crypto remains a critical theme to watch. We’re treating Bitcoin ($IBIT) like any of the Magnificent 7 stocks, and its performance is underscoring that it’s a legitimate vehicle for a bullish tech thesis.

But it doesn’t stop with Bitcoin. A diversified basket of crypto stocks offers even more beta—more leverage to this growing trend.

This aligns perfectly with the broader speculative growth theme, where high-beta plays like these are likely to be rewarded if risk appetite returns in any meaningful way.

If the market continues its recovery, crypto stocks stand to benefit from both the tech tailwinds and the speculative growth rebound.

The question isn’t whether to consider crypto—it’s how much beta you’re ready to embrace if risk appetite comes back to life.

In today’s Daily Digest, we’ll review the following:

1. New position in XLV.
2. No adjustments are needed today.
3. Closed XME at profit target.
4. Current status of open campaigns.
5. Volatility Snapshot.

Let’s dig in!

Every day, we sift through the filings to spot where the real conviction lies — cutting through the noise to highlight the most meaningful insider moves.

Here's what stood out today:

📌 Keros Therapeutics  $KROS – Madison Avenue Partners filed an original 13G reporting an initial stake of  6.40%, jumping straight onto the cap table of this rare‑disease biotech.

📌 Tyra Biosciences  $TYRA – Commodore Capital unveiled a new 5.20% stake in the precision‑oncology up‑and‑comer, another fresh biotech bet.

Here’s The Hot Corner, with data from May 14, 2025:

Click the table to enlarge it.

📌 Rep. Kelly Morrison’s Tech Dips – Rep. Morrison bought $15,000 to $50,000 slices of Broadcom  $AVGO and Meta  $META, adding more Capitol Hill cash to semis...

There weren’t any earnings reactions in the S&P 500 yesterday…

But let’s talk about something way more interesting.

Remember that monster move in NRG Energy $NRG the other day?

It was the stock's best earnings reaction ever, and it came from one of the largest “AI Utility” plays on the board.

But if NRG has the size...

Oklo $OKLO has the juice.

This stock recently surged over 1,000% in just a few months, and now it’s setting up for another rally.

Yesterday, the company reported a loss of $0.07 per share and zero revenue… and still had its best earnings reaction ever.

Why? Because the market doesn’t care about today.

It’s looking ahead to the moment this "AI Utility" company is fully online and helping power the AI Revolution.

If OKLO is above the VWAP anchored to its all-time high (currently ~31.25), the breakout is alive and well.

Thank you for reading.

- The Beat Report Team 

PS: Jeff Macke...

It’s been an incredible week in New Orleans with the whole crew and some of our closest friends.

There’s nothing like getting together in person — sharing ideas, and looking at the market from every angle.

JC opened with his “State of the Markets,” highlighting the hottest ETFs.

Strazza broke down his Breakout Multiplier strategy, and Sean followed with some live trades.

Riley covered robotaxis and flying cars, Louis talked crypto, and Rick closed with speculative tech.

Failed breakdowns are everywhere.

It’s been a recurring theme throughout this entire multi-year bull market—just when the bears appear to gain the upper hand, they drop the ball. Hard.

And every time they do, it’s our job as investors to strike—ruthlessly. That means getting long and leaning into strength while sentiment is still shaken.

Right now, money is flowing back into risk assets across the board. It’s starting to look like another textbook rinse-and-repeat of the many failed breakdowns we’ve seen in recent years.

Financials ($XLF) couldn’t hold their breakdown. Now they’re squeezing higher.

Communications ($XLC) tells the same story—back above support, and the path of least resistance is up, as long as we stay above that key level.

And perhaps the most important chart on our radar: Technology ($XLK) has also failed to break down relative to the broader market. That’s not just noise—it could be the early signal of tech reasserting itself as the leading sector.

We’ve seen this movie before. Failed breakdowns often lead to powerful upside moves.

The message here is simple: if the...